Display options
Cite
Blasi F, Di Pasquale M, Gramegna A, et al. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respir Med. 2021;190:106674doi: 10.1016/j.rmed.2021.106674.
Blasi, F., Di Pasquale, M., Gramegna, A., Viale, P., Iacobello, C., Gori, A., Tumbarello, M., Esposito, S., Richeldi, L., & Bassetti, M. (2021). A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respiratory medicine, 190106674. https://doi.org/10.1016/j.rmed.2021.106674
Blasi, Francesco, et al. "A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement." Respiratory medicine vol. 190 (2021): 106674. doi: https://doi.org/10.1016/j.rmed.2021.106674
Blasi F, Di Pasquale M, Gramegna A, Viale P, Iacobello C, Gori A, Tumbarello M, Esposito S, Richeldi L, Bassetti M. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respir Med. 2021 Dec;190:106674. doi: 10.1016/j.rmed.2021.106674. Epub 2021 Nov 01. PMID: 34788734; PMCID: PMC8559458.
Copy Download .nbib Format: NLM
Share it on

Respir Med. 2021 Dec;190:106674. doi: 10.1016/j.rmed.2021.106674. Epub 2021 Nov 01.

A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement.

Respiratory medicine

Francesco Blasi, Marta Di Pasquale, Andrea Gramegna, Pierluigi Viale, Carmelo Iacobello, Andrea Gori, Mario Tumbarello, Susanna Esposito, Luca Richeldi, Matteo Bassetti

Affiliations

  1. Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Italy. Electronic address: [email protected].
  2. Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  3. Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Italy.
  4. Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
  5. UOC Malattie Infettive, Azienda Ospedaliera per L'Emergenza Cannizzaro-Catania, Italy.
  6. Infectious Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
  7. Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  8. Pediatric Clinic, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  9. Complex Operative Unit of Pneumology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
  10. Department of Health Science, University of Genoa, Italy; Infectious Diseases Clinic, Policlinico San Martino Hospital - IRCCS, Genoa, Italy.

PMID: 34788734 PMCID: PMC8559458 DOI: 10.1016/j.rmed.2021.106674

Abstract

Influenza and pneumococcal disease represent a well-known burden on healthcare systems worldwide, as well as they still have an attributed morbidity and mortality, especially in elderly individuals and vulnerable populations. In the context of the ongoing pandemic of COVID-19, a series of considerations in favor of extensive influenza and pneumococcal vaccination campaign are emerging, including a possible reduction of hospital extra burden and saving of sanitary resources. In addition, recent studies have suggested that prior vaccinations towards non SARS-CoV-2 pathogens might confer some protection against COVID-19. In this paper the authors consider all factors in support of these hypotheses and provide a consensus statement to encourage influenza and pneumococcal vaccinations in targeted populations.

Copyright © 2021 Elsevier Ltd. All rights reserved.

Keywords: COVID-19; Influenza; Pneumococcus; Vaccination

Publication Types